Trends and characteristics of AIDS mortality in the Rio de Janeiro City after the introduction of highly active antiretroviral therapy

Brazilian Journal of Infectious Diseases

Volumn 9, Issue 3, 2005, Pages 209-215

  Saraceni, Valéria ^a,b   Da Cruz, Marly Marques ^a   De Mello Lauria, Lilian ^a   Durovni, Betina ^a  

^a Rio de Janeiro State Health Department   (Brazil)

^b NONE   (Brazil)

Author keywords

AIDS; Antiretrovirals; Mortality

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DEATH CERTIFICATE; EMERGENCY WARD; EPIDEMIC; FEMALE; HEALTH CARE QUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PUBLIC HEALTH SERVICE; UNIVERSITY HOSPITAL;

EID: 27844496763     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702005000300003     Document Type: Article

References (23)

1. Colford J.M., Jr., Segal M., Tabnak F., et al. Temporal trends and factors associated with survival after Pneumocystis carinii pneumonia in California, 1983-1992. Am J Epidemiol 1997;146:115-27.
2. Fonseca M.G.P., Barreira D. A Evolução da Mortalidade por AIDS no País, segundo sua Distribuição Geográfica. Brasília: Ministério da Saúde; 2000. Report No.: Year XIII No. 3.
3. Saraceni V., Cruz M.M., Tiago S.M.H., et al. Descriptive analysis of AIDS-related mortality after introduction of HAART in Rio de Janeiro City, Brazil. XIV International AIDS Conference, Barcelona, Spain, 2002.
4. Santo A.H., Pinheiro C.E., Jordani M.S. [Aids as underlying and associated causes of death, State of S. Paulo, Brazil, 1998]. Rev. Saude Publica 2000;34:581-8.
5. Wong T., Chiasson M.A., Reggy A., et al. Antiretroviral therapy and declining AIDS mortality in New York City. J Urban.Health 2000;77:492-500.
6. CDC (Centers For Disease Control And Prevention). HIV/AIDS Surveillance Report. Atlanta, GA: US Department of Health and Human Services, CDC; 1997. Report No.: 9. 19 p.
7. Palella F.J., Jr., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
8. Prefeitura da Cidade do Rio de Janeiro, Secretaria Municipal de Saúde: Números da Saúde: Indicadores por Área Programática 2004 Jun 2 Available from www.saude.rio.rj.gov.br.
9. FUNASA (Fundação Nacional de Saúde). Guia de vigilância epidemiológica. 5.1998. Brasilia, Ministério da Saúde.
10. Buchalla C.M., Laurenti R., Ribeiro A.F., et al. [Evaluation of the use of the International Classification of Diseases for the codification of AIDS]. Rev. Saude Publica l996;30:479-82.
11. Mello-Jorge M.H.P., Gotlieb S.L.D., Laurenti R. A saúde no Brasil: análise do període 1996 a 1999. 2001. Brasília, Organização Pan-Americana de Saúde.
12. Secretaria de Vigilância em Saúde.Programa Nacional de DST e AIDS. Critérios de definição de casos de aids em adultes e crianças. [60], 1-56.2003. Brasília, Ministério da Saúde. Śrie Manuais.
13. Camargo K.R., Jr., Coeli C.M. [Reclink: an application for database linkage implementing the probabilistic record linkage method]. Cad Saude Publica 2000;16:439-47.
14. Secretaria de Vigilância em Saúde.Programa Nacional de DST/AIDS. Boletim Epidemiológico de AIDS. Brasília: Ministério da Saúde; 2004. Report No.: Year XVII No. 1.
15. Lemos K.R., Valente J.G. [AIDS mortality in the State of Rio de Janeiro, 1991-1995]. Cad Saude Publica 2001;17:957-68.
16. Rapparini C.S., Martins M.M.C., Peixoto C.A.M., Nogueira S.A. Comparação clínico-epidemiológica de pacientes com SIDA internados em serviço especializado em intervalo de 6 anos. Rev Soc Bras Med Trop 1995;28(Supp 1):217.
17. Thuler L.C., Hatherly A.L., Goes P.N., Almeida e Silva JR. [Mortality descriptors in HIV in patients]. Rev Saude Publica 1998;32:572-8.
18. Casseb J., Orrico G.S., Feijo R.D., et al. Lack of prior antiretroviral therapy is associated with increased mortality among hospitalized patients with AIDS in Sao Paulo, Brazil. AIDS Patient.Care STDS. 2001;15:271-5.
19. Santos-Filho E.T., Menezes A.V.Q., Durovni B., et al. A qualitative study on care for PWAs in emergencies revealing demand for a new epidemiological surveillance strategy in Brazil. In 2000.
20. Castilla J., Sobrino P., De La F.L., et al. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002;16:1945-51.
21. Recsky M.A., Brumme Z.L., Chan K.J., et al. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. J Infect Dis 2004;190:285-92.
22. Nemes M.I., Carvalho H.B., Souza MF. Antiretroviral therapy adherence in Brazil. AIDS 2004;18 Suppl 3:S15-S20.
23. Paterson D.L., Swindells S., Mohr J., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.